» Articles » PMID: 20092632

Establishment of One-step SYBR Green-based Real Time-PCR Assay for Rapid Detection and Quantification of Chikungunya Virus Infection

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2010 Jan 23
PMID 20092632
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus and one of the prevalent re-emerging arbovirus in tropical and subtropical regions of Asia, Africa, and Central and South America. It produces a spectrum of illness ranging from inapparent infection to moderate febrile illness as well as severe arthralgia or arthritis affecting multiple joints. In this study, a quantitative, one-step real-time SYBR Green-based RT-PCR system for the non-structural protein 2 (nsP2) of CHIKV that can quantify a wide range of viral RNA concentrations was developed. Comparisons between the conventional semi-quantitative RT-PCR assay, immunofluorescence detection method and the one-step SYBR Green-based RT-PCR assay in the detection of CHIKV infection revealed much rapid and increase sensitivity of the latter method. Furthermore, this newly developed assay was validated by in vitro experiments in which ribavirin, a well-known RNA virus inhibitor, showed a dose-dependent inhibition of virus replication on cells that was assessed by viral infectivity and viral RNA production. Our results demonstrate the potential of this newly developed one-step SYBR Green I-based RT-PCR assay may be a useful tool in rapid detection of CHIKV and monitoring the extent of viral replication possibly in patients' samples.

Citing Articles

Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway.

Liao X, Xin J, Yu Z, Yan W, Li C, Cao L Front Cell Infect Microbiol. 2024; 14:1396279.

PMID: 38800832 PMC: 11127627. DOI: 10.3389/fcimb.2024.1396279.


Quantitative detection of chikungunya, Zika, and dengue viruses by one-step real-time PCR in different cell substrates.

Cuellar-Quimbaya A, Munoz A, Yepez-Perez Y, C I, Rodriguez A, Segura N Braz J Microbiol. 2024; 55(2):1083-1090.

PMID: 38424268 PMC: 11153482. DOI: 10.1007/s42770-023-01226-5.


Maxizyme-mediated suppression of chikungunya virus replication and transmission in transgenic mosquitoes.

Mishra P, Balaraman V, Fraser Jr M Front Microbiol. 2024; 14:1286519.

PMID: 38188571 PMC: 10766806. DOI: 10.3389/fmicb.2023.1286519.


Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017-2019.

Nguyen T, Ngwe Tun M, Cao M, Dao H, Luong C, Huynh T Viruses. 2023; 15(10).

PMID: 37896842 PMC: 10611313. DOI: 10.3390/v15102065.


Technical comparison of MinIon and Illumina technologies for genotyping Chikungunya virus in clinical samples.

de Souza L, de Oliveira I, Sales F, da Costa A, Campos K, Abbud A J Genet Eng Biotechnol. 2023; 21(1):88.

PMID: 37642827 PMC: 10465416. DOI: 10.1186/s43141-023-00536-3.


References
1.
el Mekki A, van der Groen G, PATTYN S . Evaluation of immunofluorescence and immunoperoxidase methods for antibody determination against Chikungunya, West Nile and yellow fever viruses. Ann Soc Belg Med Trop. 1979; 59(2):121-5. View

2.
Edwards C, Welch S, Chamberlain J, Hewson R, Tolley H, Cane P . Molecular diagnosis and analysis of Chikungunya virus. J Clin Virol. 2007; 39(4):271-5. DOI: 10.1016/j.jcv.2007.05.008. View

3.
Grivard P, Le Roux K, Laurent P, Fianu A, Perrau J, Gigan J . Molecular and serological diagnosis of Chikungunya virus infection. Pathol Biol (Paris). 2007; 55(10):490-4. DOI: 10.1016/j.patbio.2007.07.002. View

4.
Briolant S, Garin D, Scaramozzino N, Jouan A, Crance J . In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2003; 61(2):111-7. DOI: 10.1016/j.antiviral.2003.09.005. View

5.
Robinson M . An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955; 49(1):28-32. DOI: 10.1016/0035-9203(55)90080-8. View